Abbott Launches World's First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves; - TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with sever

Press/Media

Period5 Sep 2019

Media coverage

1

Media coverage

  • TitleAbbott Launches World's First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves; - TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with sever
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date5/09/19
    PersonsDavid Adams